Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-20
1998-09-08
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514575, 548494, 562623, A61K 3140, A61K 3119, C07D20912, C07D20918
Patent
active
058045937
ABSTRACT:
A compound of formula I or pharmaceutical acceptable salts thereof, ##STR1## wherein R.sub.1 is isopropyl, 2-methylbut-2yl, phenyl, benzyl, or 1H-indol-3ylmethyl; R.sub.2 is n-octyl, phenyl, or phenyl substituted with methoxy, fluoro, or bromo, are matrix metalloproteinase inhibitors.
REFERENCES:
MacPherson, L. J. at el. J. Med. Chem. vol. 40, pp. 2525-2523, (1997).
Jacobsen Eric Jon
Mitchell Mark Allen
Warpehoski Martha A.
Jarvis William R. A.
Pharmacia & Upjohn Company
Yang Lucy X.
LandOfFree
.alpha.-Amino sulfonyl hydroxamic acids as matrix metalloprotein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .alpha.-Amino sulfonyl hydroxamic acids as matrix metalloprotein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .alpha.-Amino sulfonyl hydroxamic acids as matrix metalloprotein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1282418